Cargando…
Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly control...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662493/ https://www.ncbi.nlm.nih.gov/pubmed/31391860 http://dx.doi.org/10.1155/2019/7056872 |
_version_ | 1783439665093672960 |
---|---|
author | Shen, Tian Xing, Guoqiang Zhu, Jingfen Cai, Yong Zhang, Shuxian Xu, Gang Feng, Yi Li, Donghua Rao, Jianyu Shi, Rong |
author_facet | Shen, Tian Xing, Guoqiang Zhu, Jingfen Cai, Yong Zhang, Shuxian Xu, Gang Feng, Yi Li, Donghua Rao, Jianyu Shi, Rong |
author_sort | Shen, Tian |
collection | PubMed |
description | BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly controlled. OBJECTIVE: We hypothesized that plant extracts-based antioxidants may benefit those with prehypertension/hypertension. METHOD: One hundred age- and gender-matched healthy older adults were randomly assigned to receive HyperBalance capsules (n=50) or placebo (n=50) at Tang-Qiao Community Health Service Center, Shanghai. Blood pressure and severity scores of hypertension treatment-related symptoms (dizziness, headache, ringing/buzzing in ears, rapid heart rate, and chest tightness) were evaluated before and after the 12-week intervention. RESULTS: Ninety-eight people completed the study, with 2 dropouts in the placebo group before the end of the study. Forty-one subjects (82%) of the HyperBalance group and 40 subjects (83.3%) of the placebo group had prehypertension (systolic blood pressures (SBP) between 130-139 and diastolic blood pressure (DBP) between 85-89mmHg), and 9 subjects (18%) in the HyperBalance group and 8 subjects (16.7%) in the placebo group had hypertension (≥140/90mmHg) before the intervention. HyperBalance significantly (P<0.01) reduced SBP from 136.18±4.38 to 124.14±3.96 mmHg and reduced DBP from 82.45±2.91 to 80.24±2.41mmHg, respectively, and reversed all 9 hypertension people to normotension or prehypertension state, whereas the placebo moderately reduced SBP from 135.79±4.22 to 132.35±4.656mmHg and reduced DBP from 82.90±3.07 to 82.27±3.01mmHg. All symptom severity scores became significantly lower in the HyperBalance group than in the placebo group after HyperBalance intervention: dizziness (0.82±0.44; vs 2.02±0.64, P<0.01); headache (0.46±0.50; vs 1.81±0.61, P<0.01); ringing/buzzing in ears (0.44±0.50; vs 1.04±0.29, P<0.01); and rapid heart rate and chest tightness (0.30±0.46; vs 0.92±0.28, P<0.01). CONCLUSION: Polyherbal supplementation such as HyperBalance could benefit old adults with prehypertension/hypertension and improve treatment-related symptoms. Further studies are needed to validate the current findings. |
format | Online Article Text |
id | pubmed-6662493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-66624932019-08-07 Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial Shen, Tian Xing, Guoqiang Zhu, Jingfen Cai, Yong Zhang, Shuxian Xu, Gang Feng, Yi Li, Donghua Rao, Jianyu Shi, Rong Evid Based Complement Alternat Med Research Article BACKGROUND: Uncontrolled blood pressure is the leading cause of mortality and disability due to associated cerebral and cardiovascular diseases and kidney failure. More than one-third of the old adult population have hypertension or prehypertension and many of their blood pressure are poorly controlled. OBJECTIVE: We hypothesized that plant extracts-based antioxidants may benefit those with prehypertension/hypertension. METHOD: One hundred age- and gender-matched healthy older adults were randomly assigned to receive HyperBalance capsules (n=50) or placebo (n=50) at Tang-Qiao Community Health Service Center, Shanghai. Blood pressure and severity scores of hypertension treatment-related symptoms (dizziness, headache, ringing/buzzing in ears, rapid heart rate, and chest tightness) were evaluated before and after the 12-week intervention. RESULTS: Ninety-eight people completed the study, with 2 dropouts in the placebo group before the end of the study. Forty-one subjects (82%) of the HyperBalance group and 40 subjects (83.3%) of the placebo group had prehypertension (systolic blood pressures (SBP) between 130-139 and diastolic blood pressure (DBP) between 85-89mmHg), and 9 subjects (18%) in the HyperBalance group and 8 subjects (16.7%) in the placebo group had hypertension (≥140/90mmHg) before the intervention. HyperBalance significantly (P<0.01) reduced SBP from 136.18±4.38 to 124.14±3.96 mmHg and reduced DBP from 82.45±2.91 to 80.24±2.41mmHg, respectively, and reversed all 9 hypertension people to normotension or prehypertension state, whereas the placebo moderately reduced SBP from 135.79±4.22 to 132.35±4.656mmHg and reduced DBP from 82.90±3.07 to 82.27±3.01mmHg. All symptom severity scores became significantly lower in the HyperBalance group than in the placebo group after HyperBalance intervention: dizziness (0.82±0.44; vs 2.02±0.64, P<0.01); headache (0.46±0.50; vs 1.81±0.61, P<0.01); ringing/buzzing in ears (0.44±0.50; vs 1.04±0.29, P<0.01); and rapid heart rate and chest tightness (0.30±0.46; vs 0.92±0.28, P<0.01). CONCLUSION: Polyherbal supplementation such as HyperBalance could benefit old adults with prehypertension/hypertension and improve treatment-related symptoms. Further studies are needed to validate the current findings. Hindawi 2019-07-14 /pmc/articles/PMC6662493/ /pubmed/31391860 http://dx.doi.org/10.1155/2019/7056872 Text en Copyright © 2019 Tian Shen et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Shen, Tian Xing, Guoqiang Zhu, Jingfen Cai, Yong Zhang, Shuxian Xu, Gang Feng, Yi Li, Donghua Rao, Jianyu Shi, Rong Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title | Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_full | Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_fullStr | Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_full_unstemmed | Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_short | Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_sort | effects of 12-week supplementation of a polyherbal formulation in old adults with prehypertension/hypertension: a randomized, double-blind, placebo-controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662493/ https://www.ncbi.nlm.nih.gov/pubmed/31391860 http://dx.doi.org/10.1155/2019/7056872 |
work_keys_str_mv | AT shentian effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT xingguoqiang effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT zhujingfen effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT caiyong effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT zhangshuxian effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT xugang effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT fengyi effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT lidonghua effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT raojianyu effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial AT shirong effectsof12weeksupplementationofapolyherbalformulationinoldadultswithprehypertensionhypertensionarandomizeddoubleblindplacebocontrolledtrial |